These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 18401833)

  • 1. The double role of epicardial adipose tissue as pro- and anti-inflammatory organ.
    Iacobellis G; Barbaro G
    Horm Metab Res; 2008 Jul; 40(7):442-5. PubMed ID: 18401833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human epicardial adipose tissue is a source of inflammatory mediators.
    Mazurek T; Zhang L; Zalewski A; Mannion JD; Diehl JT; Arafat H; Sarov-Blat L; O'Brien S; Keiper EA; Johnson AG; Martin J; Goldstein BJ; Shi Y
    Circulation; 2003 Nov; 108(20):2460-6. PubMed ID: 14581396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells.
    Fain JN
    Vitam Horm; 2006; 74():443-77. PubMed ID: 17027526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease.
    Cheng KH; Chu CS; Lee KT; Lin TH; Hsieh CC; Chiu CC; Voon WC; Sheu SH; Lai WT
    Int J Obes (Lond); 2008 Feb; 32(2):268-74. PubMed ID: 17878891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epicardial fat: from the biomolecular aspects to the clinical practice.
    Iacobellis G; Malavazos AE; Corsi MM
    Int J Biochem Cell Biol; 2011 Dec; 43(12):1651-4. PubMed ID: 21967993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease.
    Roubicek T; Bartlova M; Krajickova J; Haluzikova D; Mraz M; Lacinova Z; Kudla M; Teplan V; Haluzik M
    Nutrition; 2009; 25(7-8):762-8. PubMed ID: 19539174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epicardial fat thickness: relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity.
    Malavazos AE; Ermetici F; Cereda E; Coman C; Locati M; Morricone L; Corsi MM; Ambrosi B
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):523-30. PubMed ID: 18083357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depot-specific overexpression of proinflammatory, redox, endothelial cell, and angiogenic genes in epicardial fat adjacent to severe stable coronary atherosclerosis.
    Sacks HS; Fain JN; Cheema P; Bahouth SW; Garrett E; Wolf RY; Wolford D; Samaha J
    Metab Syndr Relat Disord; 2011 Dec; 9(6):433-9. PubMed ID: 21679057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of pro-inflammatory and pro-thrombotic state in the diagnosis of metabolic syndrome.
    Odrowaz-Sypniewska G
    Adv Med Sci; 2007; 52():246-50. PubMed ID: 18217426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered signalling and gene expression associated with the immune system and the inflammatory response in obesity.
    Gil A; María Aguilera C; Gil-Campos M; Cañete R
    Br J Nutr; 2007 Oct; 98 Suppl 1():S121-6. PubMed ID: 17922949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human visceral adipose tissue and the plasminogen activator inhibitor type 1.
    Lindeman JH; Pijl H; Toet K; Eilers PH; van Ramshorst B; Buijs MM; van Bockel JH; Kooistra T
    Int J Obes (Lond); 2007 Nov; 31(11):1671-9. PubMed ID: 17471294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human epicardial adipokine messenger RNAs: comparisons of their expression in substernal, subcutaneous, and omental fat.
    Fain JN; Sacks HS; Bahouth SW; Tichansky DS; Madan AK; Cheema PS
    Metabolism; 2010 Sep; 59(9):1379-86. PubMed ID: 20116810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease.
    Baker AR; Silva NF; Quinn DW; Harte AL; Pagano D; Bonser RS; Kumar S; McTernan PG
    Cardiovasc Diabetol; 2006 Jan; 5():1. PubMed ID: 16412224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epicardial fat: properties, function and relationship to obesity.
    Rabkin SW
    Obes Rev; 2007 May; 8(3):253-61. PubMed ID: 17444966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perivascular adipose tissue as a messenger of the brain-vessel axis: role in vascular inflammation and dysfunction.
    Guzik TJ; Marvar PJ; Czesnikiewicz-Guzik M; Korbut R
    J Physiol Pharmacol; 2007 Dec; 58(4):591-610. PubMed ID: 18195475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of adiposity as a determinant of an inflammatory milieu.
    Calabrò P; Limongelli G; Pacileo G; Di Salvo G; Golino P; Calabrò R
    J Cardiovasc Med (Hagerstown); 2008 May; 9(5):450-60. PubMed ID: 18403996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine and signalling role of adipose tissue: new perspectives on fat.
    Trayhurn P
    Acta Physiol Scand; 2005 Aug; 184(4):285-93. PubMed ID: 16026420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
    Black PH
    Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ.
    Calabro P; Yeh ET
    Subcell Biochem; 2007; 42():63-91. PubMed ID: 17612046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipose tissue inflammation in obesity and metabolic syndrome.
    Nishimura S; Manabe I; Nagai R
    Discov Med; 2009 Aug; 8(41):55-60. PubMed ID: 19788868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.